Dickson Adah
State Key Laboratory Of Respiratory Disease
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Plasmodium immunotherapy combined with gemcitabine has a synergistic inhibitory effect on tumor growth and metastasis in murine Lewis lung cancer models.
Journal: Frontiers in oncology
Published: March 07, 2023
Soluble programmed death ligand-1-induced immunosuppressive effects on chimeric antigen receptor-natural killer cells targeting Glypican-3 in hepatocellular carcinoma.
Journal: Immunology
Published: July 03, 2022
Subsequent malaria enhances virus-specific T cell immunity in SIV-infected Chinese rhesus macaques.
Journal: Cell communication and signaling : CCS
Published: March 14, 2022
The mechanisms of action of Plasmodium infection against cancer.
Journal: Cell communication and signaling : CCS
Published: March 11, 2021
Plasmodium infection prevents recurrence and metastasis of hepatocellular carcinoma possibly via inhibition of the epithelial‑mesenchymal transition.
Journal: Molecular medicine reports
Published: November 14, 2020
Plasmodium infection inhibits triple negative 4T1 breast cancer potentially through induction of CD8+ T cell-mediated antitumor responses in mice.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 19, 2020
Prodrug-Loaded Zirconium Carbide Nanosheets as a Novel Biophotonic Nanoplatform for Effective Treatment of Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 01, 2020
Experimental Treatment of SIV-Infected Macaques via Autograft of CCR5-Disrupted Hematopoietic Stem and Progenitor Cells.
Journal: Molecular therapy. Methods & clinical development
Published: February 28, 2020
A novel tumour suppressor lncRNA F630028O10Rik inhibits lung cancer angiogenesis by regulating miR-223-3p.
Journal: Journal of cellular and molecular medicine
Published: July 18, 2019
4-Aryl Pyrrolidines as Novel Orally Efficacious Antimalarial Agents. Part 2: 2-Aryl-N-(4-arylpyrrolidin-3-yl)acetamides.
Journal: ACS medicinal chemistry letters
Published: March 20, 2019
Last Updated: 09/26/2026